Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall
- 11 November 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (21), 12429-12459
- https://doi.org/10.1021/acs.jmedchem.0c00748
Abstract
Due to the limit of available treatments and the emergence of drug resistance in the clinic, invasive fungal infections are an intractable problem with high morbidity and mortality. The cell wall, as a fungi-specific structure, is an appealing target for the discovery and development of novel and low-toxic antifungal agents. In an attempt to accelerate the discovery of novel cell wall targeted drugs, this Perspective will provide a comprehensive review of the progress made to date on the development of fungal cell wall inhibitors. Specifically, this review will focus on the targets, discovery process, chemical structures, antifungal activities, and structure-activity relationships. Although two types of cell wall antifungal agents are clinically available or in clinical trials, it is still a long way for the other cell wall targeted inhibitors to be translated into clinical applications. Future efforts should be focused on the identification of inhibitors against novel conserved cell wall targets.Funding Information
- National Natural Science Foundation of China (81701981)
- Shaanxi Province (2020SF-205)
This publication has 193 references indexed in Scilit:
- E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol BiosynthesisAntimicrobial Agents and Chemotherapy, 2012
- Discovery of a Novel Class of Orally Active Antifungal β-1,3- d -Glucan Synthase InhibitorsAntimicrobial Agents and Chemotherapy, 2011
- Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and FusariosisAntimicrobial Agents and Chemotherapy, 2011
- In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and MoldsAntimicrobial Agents and Chemotherapy, 2011
- Differential Activities of Three Families of Specific β(1,3)Glucan Synthase Inhibitors in Wild-type and Resistant Strains of Fission YeastOnline Journal of Public Health Informatics, 2011
- Natural Product–Guided Discovery of a Fungal Chitinase InhibitorCell Chemical Biology, 2010
- Acetazolamide-based fungal chitinase inhibitorsBioorganic & Medicinal Chemistry, 2010
- Effect of β-1,6-Glucan Inhibitors on the Invasion Process of Candida albicans : Potential Mechanism of Their In Vivo EfficacyAntimicrobial Agents and Chemotherapy, 2009
- Discovery of a Small-Molecule Inhibitor of β-1,6-Glucan SynthesisAntimicrobial Agents and Chemotherapy, 2009
- Functional domains and interdomain communication in Candida albicans glucosamine-6-phosphate synthaseBiochemical Journal, 2007